<SEC-DOCUMENT>0001104659-26-012278-index.html : 20260210
<SEC-HEADER>0001104659-26-012278.hdr.sgml : 20260210
<ACCEPTANCE-DATETIME>20260210060154
ACCESSION NUMBER:		0001104659-26-012278
CONFORMED SUBMISSION TYPE:	SCHEDULE 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20260210
DATE AS OF CHANGE:		20260210

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CASI Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001962738
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-94039
		FILM NUMBER:		26613345

	BUSINESS ADDRESS:	
		STREET 1:		1701-1702, CHINA CENTRAL OFFICE TOWER 1
		STREET 2:		NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT
		CITY:			BEIJING
		STATE:			F4
		ZIP:			100025
		BUSINESS PHONE:		86 10 6561 8789

	MAIL ADDRESS:	
		STREET 1:		1701-1702, CHINA CENTRAL OFFICE TOWER 1
		STREET 2:		NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT
		CITY:			BEIJING
		STATE:			F4
		ZIP:			100025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CASI Pharmaceuticals Holdings, Inc.
		DATE OF NAME CHANGE:	20230118

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			He Wei-Wu
		CENTRAL INDEX KEY:			0001542073
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13D/A

	MAIL ADDRESS:	
		STREET 1:		ENTREMED, INC.
		STREET 2:		9640 MEDICAL CENTER DRIVE
		CITY:			ROCKVILLE
		STATE:			MD
		ZIP:			20850
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.B
<SEQUENCE>2
<FILENAME>tm265774d1_ex99-b.htm
<DESCRIPTION>EXHIBIT 99.B
<TEXT>
Document 2 - file: tm265774d1_ex99-b.htm

</DOCUMENT>
</SEC-DOCUMENT>